China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
09:08:20 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.530 HKD | -2.69% |
|
-1.95% | +1.80% |
| 10-19 | China Resources Pharma Unit Raises 900 Billion Yuan Via Bonds Issue | MT |
| 10-01 | China Resources Pharmaceuticals Needs More Than Distribution Scale to Win |  |
| Market Cap | 29.25B 3.73B 3.32B 3.07B 2.79B 5.23B 353B 5.32B 36.88B 14.49B 185B 13.98B 13.69B 589B | P/E 2026 * |
5.97x | P/E 2027 * | 5.6x |
|---|---|---|---|---|---|
| Enterprise Value | 78.48B 10B 8.9B 8.25B 7.47B 14.05B 947B 14.28B 98.98B 38.88B 496B 37.51B 36.73B 1,581B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.37% | Yield 2027 * | 4.73% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed | |
|
Boerse Muenchen
| 640 | Real-time |
| 1 day | -2.69% | ||
| 1 week | -1.95% | ||
| Current month | +1.80% | ||
| 1 month | +3.42% | ||
| 3 months | -5.03% | ||
| 6 months | -26.22% | ||
| Current year | +1.80% |
| 1 week | 4.5 |  | 4.76 |
| 1 month | 4.22 | | 4.76 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 25/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 12/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 14/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 31/05/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 19/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 28/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.69% | -1.95% | -5.43% | -4.23% | 3.73B | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| +0.22% | +5.37% | +39.17% | +64.51% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +0.27% | +3.44% | +21.35% | +50.15% | 291B | |
| +0.09% | +2.75% | +1.31% | +25.13% | 262B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| Average | +0.56% | +6.02% | +31.72% | +62.54% | 401.16B | |
| Weighted average by Cap. | +0.50% | +6.91% | +40.97% | +81.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 328B 41.77B 37.18B 34.46B 31.22B 58.68B 3,957B 59.66B 413B 162B 2,071B 157B 153B 6,606B | 341B 43.42B 38.65B 35.82B 32.46B 61B 4,113B 62.02B 430B 169B 2,152B 163B 159B 6,866B |
| Net income | 4.82B 615M 547M 507M 459M 863M 58.23B 878M 6.08B 2.39B 30.47B 2.31B 2.26B 97.21B | 5.18B 660M 587M 544M 493M 927M 62.5B 942M 6.53B 2.57B 32.71B 2.47B 2.42B 104B |
| Net Debt | 49.24B 6.27B 5.58B 5.18B 4.69B 8.81B 594B 8.96B 62.1B 24.39B 311B 23.53B 23.04B 992B | 42.53B 5.42B 4.82B 4.47B 4.05B 7.61B 513B 7.74B 53.64B 21.07B 269B 20.33B 19.9B 857B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | HK$4.530 | -2.69% | 8,719,000 |
| 20/10/26 | HK$4.655 | +1.09% | 9,880,500 |
| 16/10/26 | HK$4.605 | -2.23% | 7,532,028 |
| 15/10/26 | HK$4.710 | +1.95% | 16,109,099 |
| 14/10/26 | HK$4.620 | +2.67% | 13,392,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
